Medikaloka Hermina Tbk PT

IDX:HEAL

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is HEAL's stock price target?

Price Target

1 787.83 IDR

According to Wall Street analysts, the average 1-year price target for HEAL is 1 787.83 IDR with a low forecast of 1 424.1 IDR and a high forecast of 2 079 IDR.

What is Medikaloka Hermina Tbk PT's Revenue forecast?

Projected CAGR

13%

For the last 7 years the compound annual growth rate for Medikaloka Hermina Tbk PT's revenue is 15%. The projected CAGR for the next 2 years is 13%.

What is Medikaloka Hermina Tbk PT's Operating Income forecast?

Projected CAGR

26%

For the last 7 years the compound annual growth rate for Medikaloka Hermina Tbk PT's operating income is 14%. The projected CAGR for the next 2 years is 26%.

What is Medikaloka Hermina Tbk PT's Net Income forecast?

Projected CAGR

34%

For the last 7 years the compound annual growth rate for Medikaloka Hermina Tbk PT's net income is 32%. The projected CAGR for the next 2 years is 34%.